Rate My Professor Gabe Kwong

Kwong has co-founded multiple biotechnology companies and holds over 40 issued or pending patents. His publications feature in leading journals such as Nature Cancer, Nature Nanotechnology, Science Advances, Nature Biomedical Engineering, and Nature Reviews Cancer. Notable works include “Sensitizing solid tumors to CAR-mediated cytotoxicity by lipid nanoparticle delivery of synthetic antigens” (Nature Cancer, 2025), “AND-gated protease-activated nanosensors for programmable detection of anti-tumour immunity” (Nature Nanotechnology, 2025), “In vivo mRNA delivery to virus-specific T cells by light-induced ligand exchange of MHC class I antigen-presenting nanoparticles” (Science Advances, 2022), and “Synthetic Biomarkers: A 21st century path to early cancer detection” (Nature Reviews Cancer, 2021). He has received the NIH Director’s New Innovator Award (2016), NIH Director’s Pioneer Award (2022), Burroughs Wellcome Fund Career Award at the Scientific Interface (2013), Fellow of the American Institute for Medical and Biological Engineering (2024), Sigma Xi Best Faculty Paper Award (2020), and Georgia Tech CTL/British Petroleum Junior Faculty Teaching Excellence Award (2018), among others. His innovations have advanced immunoengineering and cancer diagnostics.